At long last, the FDA approved biotech salmon, AquaAdvantage, which is bred to grow to twice the size of other fish. But in contrast to every scientific study and advisory, the editorial board of The New York Times writes that the genetically-modified fish should be labelled. We take issue with that position.

A new drug for pertussis, or whooping cough, targets the bacteria's deadly toxin. It could be an important player in treating the infection, given that both vaccines and antibiotics are losing their effectiveness.

The sequence of events required to keep the human heart beating for an entire lifetime is executed over two billion times. A recent article discusses the novel approaches, based on stem cell technology and cellular reprogramming, to potentially develop cells that can mimic the heart s natural pacemaker.

Obese individuals have yet another reason to shed extra pounds -- this time to prevent knee cartilage degeneration. A recent study found that obese patients who lose at least 10 percent of their body weight can slow down the progression of cartilage damage and potentially avoid knee replacement surgery.

When Turing Pharmaceuticals bought Impax Pharmaceuticals, the sole supplier of the antiparasitic drug Daraprim, and jacked up the price more than 50-fold, patients and doctors were furious. Enter a third company, which is now selling a similar pill for a $1, compared to Turin's which cost $750. Does this dollar deal make sense? Maybe, and here's why.

Two studies show that fewer men have been screened for prostate cancer using the PSA test since 2012, when a federal panel advised against routine screenings. With doctors increasingly questioning the test's validity, that's a good thing. But the real key is whether reduction in PSA testing has led to a rise in late-stage or fatal prostate cancer.

Metformin has long been the front runner of oral medications prescribed for glucose control in Type-2 diabetics. But could it also help adolescents with Type 1? Apparently not, as a recent JAMA study failed to find any statistically-significant benefit in improving blood sugar control.

The holy grail of diabetes research has long been finding a way to administer insulin by mouth. And that goal may have been reached by scientists at the University of California at Santa Barbara, who have developed a capsule that resists the acidic environment of the stomach.

A recent CDC report provides data that shows nearly 47 percent of Americans who have been diagnosed with high blood pressure are not adequately controlling the condition. Though concerning, it's an improvement from 1999, when roughly 68 percent had high blood pressure that was not treated.

Antibiotic resistance and the possibility of approaching the end of the antibiotic era sounds fairly apocalyptic. A recent study reveals a new gene, MCR-1, that allows for a common bug, Eschirichia coli, to become resistant to polymyxin antibiotics. These are the last line of defense against infections with E. coli. This has pandemic potential.